5 completed, 2 not yet recruiting, 2 unknown. 9 Phase 2, 4 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 5, Not yet recruiting 2, Unknown 2 |
| Phase 3 | 4 | Completed 3, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
Follow Habits: new trials by email Literature Review of Habits trials Research Report on Habits
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa Donepezil - Anorexia Nervosa | Phase 2 | Not yet recruiting | New York State Psychiatric Institute | 10 | 2027-01-01 | 2026-10-23 |
| Acetylcholinesterase Inhibitor in Anorexia Nervosa: Multicenter, Double-Blind, Placebo-Controlled Trial Donepezil 2.5 mg, Donepezil 5 mg, Placebo Comparator - Anorexia Nervosa Restricting Type | Phase 2 | Not yet recruiting | Centre Hospitalier St Anne | 147 | 2024-11-01 | 2024-11-14 |
| CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders) 5% polymer gel with CBD application, 10% polymer gel with CBD application, Placebo intervention - Temporomandibular Disorder, Myofascial Pain | Phase 2 / Phase 3 | Unknown | Medical University of Silesia | 30 | 2023-07-18 | 2023-07-21 |
| Botulinum Toxin A Injectable Solution in the Management of Bruxism: A Clinical Trial Study onabotulinumtoxinA - Nocturnal Bruxism | Phase 2 | Unknown | Riyadh Colleges of Dentistry and Pharmacy | 20 | 2018-11-13 | 2019-02-01 |
| The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders Platelet-Rich Plasma intramuscular injections, Placebo Comparator: 0,9% NaCl intramuscular injections - PRP, Temporomandibular Disorder | Phase 2 / Phase 3 | Completed | Medical University of Silesia | 58 | 2017-12-07 | 2019-01-04 |
| Exercise Habit and M-PAC M-PAC Group - Public Health | Phase 2 / Phase 3 | Completed | University of Victoria | 94 | 2015-01-01 | 2016-06-01 |
| Smoking Habits and Smoking Cessation in Young Adults varenicline, Nicotine cutaneous patch 15mg/16h, Nicotine cutaneous patch 10mg/16h - Smoking Cessation, Smoking | Phase 2 / Phase 3 | Completed | Tuula Toljamo | 300 | 2012-05-01 | 2017-06-05 |
| Occlusal Adjustment as Treatment for Chronic Orofacial Pain Occlusal adjustment, Placebo occlusal adjustment - Temporomandibular Joint Disorders, Orofacial Pain | Phase 1 / Phase 2 | Completed | University of Santiago de Compostela | 21 | 2009-05-01 | 2013-07-26 |
| Antibody and Safety Study of 6 Doses of NicVAX in Smokers 3'-aminomethyl-Nic r-EPA Conjugate (NicVAX®) - Smoking | Phase 1 / Phase 2 | Completed | Nabi Biopharmaceuticals | 74 | 2008-01-01 | 2012-05-09 |
Bruxism (4) · Temporomandibular Joint Disorders (3) · Anorexia Nervosa (2) · Facial Pain (2) · Feeding and Eating Disorders (2) · Smoking (2) · Anorexia (1) · Motor Activity (1) · Myalgia (1) · Pain (1) · Sleep Bruxism (1) · Smoking Cessation (1) · Temporomandibular Joint Dysfunction Syndrome (1)
Behavior (9) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Stomatognathic Diseases (4) · Tooth Diseases (4) · Craniomandibular Disorders (3) · Jaw Diseases (3) · Joint Diseases (3) · Mandibular Diseases (3) · Mental Disorders (3) · Muscular Diseases (3) · Musculoskeletal Diseases (3) · Neurologic Manifestations (3) · Nervous System Diseases (2)
Donepezil (2) · Botulinum Toxins, Type A (1) · NicVAX (1) · Nicotine Chewing Gum (1) · Occlusal Adjustment (1) · Varenicline (1)
Medical University of Silesia (2) · Centre Hospitalier St Anne (1) · Nabi Biopharmaceuticals (1) · New York State Psychiatric Institute (1) · Riyadh Colleges of Dentistry and Pharmacy (1) · Tuula Toljamo (1) · University of Santiago de Compostela (1) · University of Victoria (1)
Poland (2) · United States (2) · Canada (1) · Finland (1) · Saudi Arabia (1) · Spain (1)
Aleksandra Nitecka-Buchta, DMD (1) · Matt Hohenboken, MD, PhD (1) · Navin Kaushal, PhD (1) · Pentti Nieminen, PhD (1)